PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

This is a Phase II treatment study analyzing the role of preoperative chemotherapy, preoperative laparoscopic HIPEC, and gastrectomy with CRS/HIPEC in gastric adenocarcinoma patients with cytology-positive only carcinomatosis, radiologically-occult carcinomatosis, or radiology apparent peritoneal-surface only metastatic disease.

Trial Details

NCT ID
NCT07178808
Phase
PHASE2
Sponsor
Banner Health
Status
RECRUITING
Cancer Type
Gastric Cancer
Interventions
  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Locations (sample)
  • Gilbert, Arizona, United States|33.35283,-111.78903

Key Eligibility Criteria

  • 1\) Age 18 years and above. There will be no upper age restriction. 2)ECOG performance status ≤ 2. (See Appendix A -ECOG Performance Status Scale).…
  • Adequate renal, and bone marrow function:
  • Leukocytes \>= 3,000/uL
  • Absolute neutrophil count \>= 1,500/uL

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →